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Abstract 
Purpose: To evaluate the antitumor effect of a latex extract from Euphorbia tirucalli Linn. 
(Euphorbiaceae) and its toxicity. 
Methods: Aqueous ethanol and petroleum ether extracts were obtained through maceration. .Maximum 
tolerated dose was determined in healthy mice. Antitumor activity was measured in Ehrlich ascites 
tumor-bearing mice treated with the extract through intraperitoneal injection (62.5, 125 or 250 mg/kg) 
every 48 h (four doses). Efficacy was assessed by weight gain, abdominal circumference, volume of 
ascitic fluid and packed tumor cells, tumor cell viability and survival. Toxicity indicators were serum 
glucose, triglycerides, total proteins, activity of alanine and aspartate aminotransferases and mass of 
heart, spleen, kidney and liver. A hemolysis assay was also performed.  
Results: Doses of 62.5 and 125 mg/kg caused no antitumor activity, while 250 mg/kg dose reduced 
weight gain (3-fold), abdominal circumference and volume of ascitic fluid (> 50 %) and packed cells (50 
%), but lowered tumor cell viability (40 %). However, mice treated with the extract survived for a shorter 
time than control mice. Furthermore, the 250 mg/kg dose caused cardiac atrophy, splenomegaly and 
fasting hyperglycemia. The extract caused hemolysis, and the half-maximal effective concentration 
(EC50) was 1.6 (0.9 – 2.7) mg/mL. 
Conclusion: Euphorbia tirucalli extract inhibits Ehrlich ascites tumor in mice, but the therapeutic dose is 
also harmful to non-tumor tissues.  
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Some ethnobotanical articles reported that 
people from different communities and rural 
workers in Brazil have used the latex of 
Euphorbia tirucalli Linn. (Euphorbiaceae) for the 
traditional treatment of cancer. In most cases, 
the recommendation is to dilute some drops of 
latex into water and take it orally [1-3]. In Brazil, 
Euphorbia tirucalli (E. tirucalli) is known as 
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“aveloz”. This plant is originally from Africa and is 
found in many tropical regions, grown as an 
evergreen plant containing latex in the aerial 
parts [–1-4]. There are also some claims that the 
latex is used on external warts [3]. 
 
Some investigations evaluating the antitumor 
activity of E. tirucalli support its potential for the 
treatment of cancer. However, literature is still 
lacking in vivo data and safety data. One study 
has shown that euphol, a triterpene from E. 
tirucalli inhibited the growth of gastric cancer 
cells by ERK 1/2-mediated apoptosis [5]. In vivo, 
one preliminary report postulated that Ehrlich 
tumor-bearing mice had myelosuppression and 
increased numbers of spleen granulocyte-
macrophage colony forming units. The treatment 
of these animals with E. tirucalli aqueous 
ethanolic extract (125, 250 or 500 mg/kg) 
through gavage daily for five days stimulated 
marrow myelopoiesis and reduced spleen colony 
formation [6].  
 
Other studies showed that E. tirucalli is toxic [4,7-
11]. It contains 4-deoxyphorbol ester, which can 
suppress the immune system and promote tumor 
growth. The endemicity of Burkitt's lymphoma 
coincides with profusion of E. tirucalli in tropical 
Africa [4]. The latex is extremely irritating to the 
skin and mucosa [8]. The oral administration of 
one drop of latex for 18 weeks caused 
splenomegaly in healthy mice [9]. A recent study 
demonstrated that eutirucallin, a lectin from the 
latex presents proinflammatory properties [10]. 
The aqueous extract from E. tirucalli caused 
cytotoxicity, genotoxicity and changes in 
antioxidant gene expression in human leukocytes 
[11]. 
 
With this background, it is evident that the 
internal administration of products from E. 
tirucalli must be evaluated deeper. Even when it 
is considered an antitumor activity, when toxicity 
can be used with therapeutic purposes, this 
cannot be useful if it is not controllable and 
directed preferably against tumor cells. The aim 
of the current study was to enhance the 
understanding of the antitumor activity and 






The aerial parts of E. tirucalli were collected 
between June and July 2013 in the western 
region of Santa Catarina, Brazil, and 
authenticated by Professor Jasper J Zanco, from 
Universidade do Sul de Santa Catarina (Unisul). 
A voucher specimen (no. R-SRS50033) was 
deposited at Herbarium Laelia purpurata of the 
same University. This work complied with the 




The aerial parts of E. tirucalli consist of fleshy 
branches containing latex. Therefore, aerial parts 
were milled fresh and kept in shake-assisted 
maceration (1:2 weight/volume) for 2 days, 
repeated 3 times. An aqueous ethanol extract 
was made using water:ethanol (1:8). Another 
extract was made in parallel using petroleum 
ether. All solvents were Vetec® ACS grade 
reagents. The solvents were eliminated under 
reduced pressure. Extraction performances were 
calculated in mass of dried extract (g) and yield 
(%), taking into consideration the mass of the 




The study was conducted in compliance with 
international (NIH) guidelines [14] and had the 
approval of the ethics committee of Unisul (no. 
13.027.4.03.IV). Male Balb/c mice (20 ± 5 g) 
were housed under controlled conditions in the 
Laboratory of Neurosciences from Unisul, having 
food and water ad libitum. Before experiments, 
mice were fasted for 6 h. Animals were allowed 
to acclimatize (12 h light-dark cycle, 22 ± 2°C, 60 
% relative humidity) for at least 5 days before the 
experiments. 
 
Determination of maximal tolerated dose 
 
Groups of healthy mice (n = 6) were treated 
through intraperitoneal injections (i.p.) with up to 
four doses of extract (50, 100, 250, 350 or 450 
mg/kg) given every 48 h to determine the 
maximum tolerated dose by verifying the 
occurrence of death, hair erection, 
aggressiveness, dullness, inactivity and loss of 
appetite [15]. 
 
Tumor induction and treatment 
 
Ehrlich carcinoma (5 x 106 cells) was inoculated 
into the abdomen of another set of animals [16]. 
Inoculation day was considered “day zero” when 
animals were weighed and the abdominal 
circumference was measured. Twenty-four hours 
later, animals were divided into 4 groups (n = 
12/each), including a control group treated (i.p.) 
with saline (50 µL) and 3 test-groups which 
received aqueous ethanol extract (i.p.) at 62.5, 
125 or 250 mg/kg. Four doses were administered 
in total. Each dose was given every 48 h. 
Kviecinski et al 
Trop J Pharm Res, December 2016; 15(12): 2597  
 
Evaluation of antitumor activity 
 
On day 10, mice were weighed and the 
abdominal circumferences were measured one 
more time. Half of each group was euthanized 
(n=6), and the ascitic fluid was collected in 
graduated FalconTM conical tubes. Tubes were 
centrifuged at 5.000 g (5 min) to measure packed 
tumor cells volume [16]. Viability of tumor cells 
was assessed through the trypan blue assay 
[17]. Cells were counted by a TC10 counter (Bio-
Rad, USA). Inhibition of tumor growth (ITG) was 
calculated with basis on abdominal 
circumference change (AC) using Equation 1 
[18]: 
 
ITG (%) = [AC (test-group) x 100/AC (control)] – 10 
…………... (1) 
 
Evaluation of mice survival  
 
The remaining animals of each group (n=6) were 
monitored on a daily basis to evaluate survival 
using Kaplan-Meier method [19]. 
 
Determination of toxicity 
 
The mass of heart, spleen, kidneys and liver from 
mice treated with the antitumor effective dose of 
extract (250 mg/kg) and mice from the control 
group (n = 6) was measured in a Shimadzu AUY 
200 analytical balance (Japan) [15]. Blood 
samples were collected for estimating serum 
glucose, triglycerides, total proteins and activity 
of aspartate and alanine - aminotransferases 




Hemolytic test was performed in triplicate using 
96-well plates [20]. Each well received saline 
(100 µL 0.85 % NaCl and 10 mM CaCl2). Then, 
100 µL of saline containing extract (0.08 - 2.5 
mg/mL) were added. The negative control 
(hemolysis 0 %) contained only saline. Triton X-
100 (20 µL) was added as positive control (100 
% hemolysis). Each well received a 2 % 
suspension of mouse erythrocytes. After 
incubation at room temperature (30 min) and 
centrifugation (5.000 g for 5 min), hemoglobin 
was quantified at 540 nm. The half maximal 
effective concentration (EC50) and 95 % 
confidence intervals were calculated using Graph 




Data are presented as mean ± standard 
deviation or confidence intervals. Statistical 
analysis was carried out using Graph Pad Prism 
software, analysis of variance (ANOVA) and 





The yield of aqueous ethanol and petroleum 
ether extractions was 0.86 ± 0.05 and 0.14 ± 
0.02, respectively. Thus, the extraction yield 
using water-ethanol was much higher (6-fold) 
than the petroleum ether extraction. Therefore, 
the aqueous ethanol extract was selected for 
screening for antitumor activity and toxicity.  
 
Figure 1 shows the mortality of healthy mice 
following a first, second, third and fourth 
administration of extract. The maximum tolerated 
dose was 250 mg/kg, which caused neither 
mortality nor behavior changes. 
 
Considering the treatments of Ehrlich ascites 
tumor-bearing mice, Figure 2 (A) shows that the 
weight gain in mice from the saline-treated 
control group was 12.8 ± 3 g, which is a weight 




Figure 1: Mortality of healthy mice receiving doses of Euphorbia tirucalli aqueous ethanol extract every 48 h 
through intraperitoneal injections (n=6/each group) 
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Figure 2: Weight gain (A), abdomen circumference (B), volume of ascitic fluid (C) and packed tumor cells (D) in 
Ehrlich ascites tumor-bearing mice treated with Euphorbia tirucalli aqueous ethanol extract (62.5, 125 or 250 
mg/kg) and the saline-treated control. Data are as means ± SD (n=12 in A and B, whereas n=6 in C and D). 
***statistical difference compared to the control (p < 0.01) 
 
There were no differences in weight gain 
between the control and the groups dosed with 
extract at 62.5 and 125 mg/kg. The group dosed 
at 250 mg/kg had a weight gain of 3.6 ± 1.8 g, 
showing a strong reduction compared to the 
control group. 
 
Figure 2 also shows data of abdominal 
circumference (B), volume of ascitic fluid (C) and 
packed tumor cells (D). Again, no differences 
were observed between the control and mice 
treated with either 62.5 or 125 mg/kg. Mice 
treated with 250 mg/kg showed an abdominal 
circumference determined at 1.5 ± 0.6 cm on 
average, which means a reduction close to 50 % 
compared to the control (Figure 2 B). A similar 
trend was observed for the volume of ascitic fluid 
(Figure 2 C). The packed cells volume in mice 
from the control was 4.7 ± 0.1 mL, this value was 
2.9 ± 0.2 mL in mice treated with extract at 250 
mg/kg. 
 
Figure 3 (A) shows tumor cell viability. Only the 
treatment done with extract at 250 mg/kg 
reduced the number of viable tumor cells 
compared to the control. Therefore, if taken 
together the above results suggest an antitumor 
activity for the extract at 250 mg/kg. The 
inhibition of tumor growth was calculated at > 
40%. This corroborates claims for the antitumor 




Figure 3: Number of viable tumor cells in mice treated with Euphorbia tirucalli aqueous ethanol extract. Data are 
means ± SD (n=6/each group). ***statistical difference compared to the control (p < 0.01) (A). Lifespan of Ehrlich 
tumor-bearing mice treated with the extract at 62.5, 125 or 250 mg/kg and the saline-treated control (n=6/each 
group) (B) 
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Figure 3 (B) shows the percentage of survivors 
after treatments. Increase in the area under the 
curves indicated an increase of survival. The 
smallest areas corresponded to mice treated with 
the extract at 125 and 250 mg/kg. The area was 
slightly larger when mice were dosed at 62.5 
mg/kg. However, all mice treated with extract 
survived a shorter time than mice from the 
control.  
 
Figure 4 shows the mass of organs of mice 
treated with extract at 250 mg/kg and the control. 
Figures 4 (A) and 4 (B) show that the mass of 
kidneys and liver were not affected. Figures 4 (C) 
and 4 (D) show evidences of cardiac atrophy and 
splenomegaly in mice receiving the extract. 
 
Some serum parameters were measured to 
evaluate the toxicity of extract given at 250 
mg/kg (Figure 5). No differences were verified 
neither in terms of triglycerides (5 A), total 
proteins (5 B) nor activity of AST and ALT (5 
C/D). However, mice treated with extract had 
fasting hyperglycemia compared to the control 
(Figure 5 E).  
 
 
Figure 4: Mass of organs of Ehrlich tumor-bearing mice treated with Euphorbia tirucalli aqueous ethanol extract 
at 250 mg/kg (intraperitoneally) (closed bars). Saline-treated control group (opened bars). Data are means ± SD 
(n=6/each group). ***statistical difference compared to the control (p < 0.01) 
 
 
Figure 5: Serum triglycerides (A), total proteins (B), activities of aspartate AST (C) and alanine-
aminotransferases ALT (D) and glycemia (E) in Ehrlich tumor-bearing mice treated with Euphorbia tirucalli 
aqueous ethanol extract (250 mg/kg, intraperitoneally) (closed bars). Saline-treated control (opened bars). Data 
are means ± SD (n=6/each group). ***statistical difference (p < 0.01) 
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Figure 6 shows that E. tirucalli aqueous ethanol 
extract caused concentration-dependent 
hemolysis. The EC50 value was 1.6 (0.9 – 2.7) 
mg/mL.  

















Figure 6: Hemolysis caused by Euphorbia tirucalli 
aqueous ethanol extract. Data of three independent 




Some ethnobotanical studies and data of in vitro 
experiments suggest usefulness of E. tirucalli for 
cancer treatment [1-3,6]. The plant latex is toxic 
[4,8-11]. To be worthy therapeutically, this 
toxicity had to be evaluated when considering 
internal administration. 
 
The overall data of the first phase of this 
investigation suggested an antitumor action of E. 
tirucalli extract administered at 250 mg/kg, 
capable to kill tumor cells (Figure 3A). That 
caused reduction of volumes of ascitic fluid and 
packed tumor cells (Figure 2). The ascitic fluid 
volume gives information of requisition and 
nutritional status of tumor and availability of 
nutrients, whereas the packed tumor cells 
volume represents the tumor size itself [21]. 
 
This investigation started by evaluating healthy 
mice to determine the maximum tolerated dose 
of extract administered intraperitoneally (250 
mg/kg) (Figure 1). Initially, 250 mg/kg was 
considered safe because healthy mice did not 
die and had no behavioral changes. Figure 1 
shows that doses above 250 mg/kg induced 
toxicity (> 50 % of death after a single dose at 
350 mg/kg within 24 h). Therefore, a range of 
doses (62.5 to 250 mg/kg) was tested for 
antitumor activity. 
 
Lower doses (62.5 and 125 mg/kg) were 
ineffective. Only 250 mg/kg caused tumor growth 
inhibition. Nevertheless, data showed that the 
effect was poorly selective and compromised 
other organs. All tumor-bearing mice treated with 
the extract survived a shorter time than mice 
from the control. Dose of 250 mg/kg was safe in 
healthy animals (Figure 1), but this was the 
threshold of safety because it weakened tumor-
bearing mice. These mice had cardiac atrophy, 
splenomegaly (Figure 4 C/D) and fasting 
hyperglycemia (Figure 5E).  
 
Some drugs used for cancer are tricky because 
they can cause cardiotoxicity [22]. A cardiac 
atrophy normally represents a secondary 
consequence resulting from a larger systemic 
phenomena on [23]. It is possible that in this 
case it was induced by the extract. 
 
Splenomegaly can also indicate a limitation for 
the treatment. In principle, the enlargement of the 
spleen can be associated with a variety of 
etiologies (infectious, neoplastic or congestive). 
When these causes are ruled out, splenomegaly 
is normally a response to hyperfunction in any 
disorder that usually involves abnormal 
erythrocytes being destroyed in the spleen [24]. 
The interpretation of data suggesting 
splenomegaly in the current study had to 
consider that the experiment was done in tumor 
bearing mice. Data suggested that tumor-bearing 
mice treated with the extract from E. tirucalli at 
250 mg/kg had enlarged spleens compared to 
the control group (Figure 4D). Previously, 
Varrichio et al [9] reported that healthy mice 
treated with latex from E. tirucalli had 
splenomegaly. 
 
Irrespective of whether splenomegaly was 
associated with the toxicity of extract, it was also 
verified if the extract was able to cause 
hemolysis. Compounds possessing biological 
activity may not be useful if they cause 
hemolysis. The hemolytic assay may reveal 
some information about the toxicity mechanism 
[25]. Data showed that E. tirucalli extract caused 
hemolysis (Figure 6). 
 
The final evidence showing that the effective 
dose of the extract was poorly selective was 
because treated mice had fasting hyperglycemia 
(Figure 5E). In toxicology, fasting hyperglycemia 
is used as a marker to screen compounds with 




E. tirucalli aqueous ethanol extract administered 
intraperitoneally inhibits the growth of Ehrlich 
ascites tumor in mice, but only at doses that are 
also harmful to non-tumor tissues. Further 
studies may be required to explore how the 
extract is developed to therapeutic doses without 
toxic effects on normal cells. 
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